The World of Health & Medicine News

Study strengthens link between maternal diabetes and autism

Study strengthens link between maternal diabetes and autism

A large new study adds to evidence that diabetes during pregnancy is linked with an increased risk of brain and nervous system problems in children, including autism, researchers say.

Whether diabetes actually causes those problems remains unclear. But when mothers have diabetes while pregnant, children are 28% more likely to be diagnosed with a neurodevelopmental disorder, according to an analysis of data pooled from 202 earlier studies involving more than 56 million mother-child pairs.

The risks for children of mothers with diabetes during pregnancy were 25% higher for autism, 30% higher for attention deficit hyperactivity disorder and 32% higher for intellectual disability. They were also 20% higher for trouble with communication, 17% higher for movement problems and 16% higher for learning disorders than in children whose mothers did not have diabetes while pregnant.

Diabetes diagnosed before pregnancy appeared to confer a 39% higher risk for one or more of these neurodevelopmental disorders compared with gestational diabetes that begins in pregnancy and often resolves afterward, the researchers reported in The Lancet Diabetes & Endocrinology, opens new tab.

Diabetes affects up to 9% of pregnancies in the United States, with the incidence rising, according to the U.S. Centers for Disease Control and Prevention.

Seven of the earlier studies compared affected children with siblings. These analyses did not find an effect from mothers’ diabetes, which suggests that shared genetic or familial factors might be contributing to the increased risk, the authors noted.

The findings emphasize the importance of medical support for women at risk of developing diabetes and the continuous monitoring of their children, the researchers said.

The association of maternal diabetes with autism in offspring is well known, said Dr. Magdalena Janecka of NYU Grossman School of Medicine, who studies links between in utero exposures and child development but was not involved in the new research.

A large “meta-analysis” like this one allows for analyses of subgroups, such as mothers with pre-existing vs gestational diabetes, or children with autism vs those with ADHD or movement disorders, but it cannot prove cause and effect, Janecka said.

“Meta-analyses allow us to compare groups more precisely. At the same time, they are not bringing us any closer to understanding the causes or the underlying mechanisms.”

The study comes as Trump administration health officials have called for further research into whether vaccines are a cause of autism, a claim long championed by new Health Secretary Robert F. Kennedy Jr. that has been debunked by established science.

spot_img

Explore more

spot_img

DHL delivers the world’s first mobile heart clinic to Burundi

DHL delivers the world's first mobile heart clinic to Burundi - DHL Global Forwarding has successfully transported the world’s first mobile heart clinic for children...

WHO members close to accord on tackling future pandemics, sources say

WHO members close to accord on tackling future pandemics, sources say Members of the World Health Organization are close to a deal on a treaty...

Obesity-drug pioneers and 13,508 physicists win US$3-million Breakthrough Prizes

Obesity-drug pioneers and 13,508 physicists win US$3-million Breakthrough Prizes Five scientists who contributed to the development of the blockbuster weight-loss drugs Ozempic and Wegovy have picked up...

Kennedy sets September deadline to identify cause of rising US autism...

Kennedy sets September deadline to identify cause of rising US autism rates The United States will identify the cause of autism by September, Secretary of...

Rhythm Pharma’s drug for rare obesity meets late-stage trial goal

Rhythm Pharma's drug for rare obesity meets late-stage trial goal Rhythm Pharmaceuticals (RYTM.O), opens new tab said on Monday its drug Imcivree notably reduced weight in patients...

US FDA to phase out animal testing in drug development

US FDA to phase out animal testing in drug development The U.S. Food and Drug Administration said on Thursday it plans to replace animal...

US FDA approves syringe version of Argenx’s immune disorder drug

US FDA approves syringe version of Argenx's immune disorder drug The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx...

South Sudan cholera patients died walking to clinic after US cut...

South Sudan cholera patients died walking to clinic after US cut aid, charity says Eight people in South Sudan, including five children, died on a...